loader
Please Wait
Applying Filters...

Seqens Seqens

X

Approved Drug Products containing 75994 listed in the FDA Orange Book. Original Data : FDA Website

Client Virtual Booth
Menu
Left Arrow
Right Arrow
Filters Filter
Cross PopUp
FILTER :

filter

01 CHARTWELL RX (6)

filter

01 TABLET;ORAL (6)

filter

01 RX (6)

filter

01 LISINOPRIL (6)

filter

01 No (6)

URL Supplier Web Content
TABLET; ORAL
5MG
2002-07-01
75994
LISINOPRIL
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; ORAL
30MG
2002-07-01
75994
LISINOPRIL
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; ORAL
10MG
2002-07-01
75994
LISINOPRIL
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; ORAL
2.5MG
2002-07-01
75994
LISINOPRIL
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; ORAL
40MG
2002-07-01
75994
LISINOPRIL
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content
URL Supplier Web Content
TABLET; ORAL
20MG
2002-07-01
75994
LISINOPRIL
RX
No
AB
ASK
US
PHARMACOMPASS
Upload
your Marketing & Sales content

Looking for FDA Orange Book APPLICATION 75994

Looking for FDA Orange Book APPLICATION 75994 6

19

Chartwell Pharmaceuticals llc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is LISINOPRIL, with a corresponding application number 75994.

Regulatory Information RX

With a dosage strength 5MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug No

Approved since 2002-07-01

Therapeutic Equivalence (TE) Code AB

18

Chartwell Pharmaceuticals llc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is LISINOPRIL, with a corresponding application number 75994.

Regulatory Information RX

With a dosage strength 30MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug No

Approved since 2002-07-01

Therapeutic Equivalence (TE) Code AB

17

Chartwell Pharmaceuticals llc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is LISINOPRIL, with a corresponding application number 75994.

Regulatory Information RX

With a dosage strength 10MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug No

Approved since 2002-07-01

Therapeutic Equivalence (TE) Code AB

16

Chartwell Pharmaceuticals llc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is LISINOPRIL, with a corresponding application number 75994.

Regulatory Information RX

With a dosage strength 2.5MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug No

Approved since 2002-07-01

Therapeutic Equivalence (TE) Code AB

15

Chartwell Pharmaceuticals llc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is LISINOPRIL, with a corresponding application number 75994.

Regulatory Information RX

With a dosage strength 40MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug No

Approved since 2002-07-01

Therapeutic Equivalence (TE) Code AB

14

Chartwell Pharmaceuticals llc, based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA.

One of their notable products is LISINOPRIL, with a corresponding application number 75994.

Regulatory Information RX

With a dosage strength 20MG

Dosage Form Route TABLET; ORAL

Reference Listed Drug No

Approved since 2002-07-01

Therapeutic Equivalence (TE) Code AB

Post Enquiry
POST ENQUIRY